Ameriprise’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
103,955
+57,507
| +124% | +$646K | ﹤0.01% | 3173 |
|
|
2025
Q1 | $212K | Sell |
46,448
-212,425
| -82% | -$971K | ﹤0.01% | 3740 |
|
|
2024
Q4 | $1.46M | Buy |
258,873
+32,817
| +15% | +$185K | ﹤0.01% | 3052 |
|
|
2024
Q3 | $1.09M | Buy |
226,056
+46,638
| +26% | +$226K | ﹤0.01% | 3178 |
|
|
2024
Q2 | $876K | Buy |
179,418
+79,458
| +79% | +$388K | ﹤0.01% | 3202 |
|
|
2024
Q1 | $1.33M | Sell |
99,960
-3,713
| -4% | -$49.3K | ﹤0.01% | 3052 |
|
|
2023
Q4 | $1.45M | Buy |
103,673
+41,643
| +67% | +$581K | ﹤0.01% | 3032 |
|
|
2023
Q3 | $823K | Buy |
62,030
+14,008
| +29% | +$186K | ﹤0.01% | 3227 |
|
|
2023
Q2 | $900K | Sell |
48,022
-9,038
| -16% | -$169K | ﹤0.01% | 3216 |
|
|
2023
Q1 | $823K | Buy |
57,060
+15,766
| +38% | +$227K | ﹤0.01% | 3236 |
|
|
2022
Q4 | $799K | Sell |
41,294
-2,315
| -5% | -$44.8K | ﹤0.01% | 3227 |
|
|
2022
Q3 | $1.5M | Buy |
43,609
+1,894
| +5% | +$65.1K | ﹤0.01% | 2914 |
|
|
2022
Q2 | $637K | Buy |
41,715
+10,462
| +33% | +$160K | ﹤0.01% | 3309 |
|
|
2022
Q1 | $713K | Buy |
31,253
+3,255
| +12% | +$74.3K | ﹤0.01% | 3342 |
|
|
2021
Q4 | $1.03M | Sell |
27,998
-610
| -2% | -$22.5K | ﹤0.01% | 3236 |
|
|
2021
Q3 | $1.35M | Buy |
28,608
+2,326
| +9% | +$109K | ﹤0.01% | 3032 |
|
|
2021
Q2 | $1.58M | Buy |
+26,282
| New | +$1.58M | ﹤0.01% | 3019 |
|